Greenline Clinical Research is internationally recognized as the leading North America Pacific centered global biotech contract research organization (CRO).
Greenline Clinical Research has built on our deep experience and coverage across Canada with expansion into North America region and India to provide global clinical development support to our global client base.
Greenline Clinical Research has office in Canada and site partnerships with over 40 key medical institutions and experience with >1500 clinical trial sites
Greenline Clinical Research provides clinical development services across all clinical trial including regulatory and drug development consulting, protocol design and writing, feasibility assessments, local ethics committee and regulatory submissions, clinical monitoring, project and vendor management, data management, statistical analysis, data visualization and analytics, DCTs, medical advisory and medical monitoring, pharmacovigilance, central lab services and clinical study report writing. We work to the highest quality standards, in line with ICH-GCP, global regulatory agencies and underpinned by robust processes in line with our ISO 9001 accredited Quality Management system.
Greenline Clinical Research has broad therapeutic experience with a particular focus on oncology/immuno-oncology, infectious disease/vaccines, neurology, and rare diseases.
As a biotech specialist, Greenline Clinical Research has extensive medical, scientific, regulatory, and operational expertise with advanced and novel therapeutics, across all therapeutic areas, including cell & gene therapies, precision medicine, RNA based vaccines and therapeutics, ADCs, microbiome, radiopharmaceuticals and more.
Our geographic presence, our depth of expertise and services, our operational infrastructure, and investments in technological advancements, combine to provide the perfect solution to accelerate global clinical development for biotech Sponsors.